Drugs for Filarial Elephantiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 50)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Ivermectin |
Approved, Investigational, Vet_approved |
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
70288-86-7 |
6474909
|
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
HMS2089M09
I 8898
I8898_SIGMA
|
Ivermectin
IVERMECTIN
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick_516
Prestwick2_000156
Prestwick3_000156
S1351_Selleck
SMR000857211
|
|
2 |
|
Albendazole |
Approved, Vet_approved |
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
54965-21-8 |
2082
|
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(propylthio)-1H-Benzimidazol-2-yl)carbamate methyl ester
(5-(propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-(propylthio)-1H-Benzimidazol-2-yl)carbamic acid methyl ester
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
5-(propylthio)-2-carbomethoxyaminobenzimidazole
5-(propylthio)-2-Carbomethoxyaminobenzimidazole
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
albendazole
Albendazole
Albendazole (JAN/USP/INN)
Albendazole [USAN:INN:BAN:JAN]
Albendazole armstrong brand
Albendazole Armstrong Brand
Albendazole diba brand
Albendazole Diba Brand
Albendazole fustery brand
Albendazole Fustery Brand
Albendazole hormona brand
Albendazole Hormona Brand
Albendazole liferpal brand
Albendazole Liferpal Brand
Albendazole monohydrochloride
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole noé-socopharm brand
Albendazole pfizer brand
Albendazole Pfizer Brand
Albendazole sanicoopa brand
Albendazole Sanicoopa Brand
Albendazole valdecasas brand
Albendazole Valdecasas Brand
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong brand OF albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
Bendapar
BIDD:GT0615
Bilutac
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
ChemDiv1_000190
ChemDivAM_000003
CID2082
CPD000036735
D00134
D015766
DB00518
Diba brand OF albendazole
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, mediamix V
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery brand OF albendazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
Hormona brand OF albendazole
|
Hormona Brand of Albendazole
HSDB 7444
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
Liferpal brand OF albendazole
Liferpal Brand of Albendazole
LS-50618
Lurdex
Mediamix V disthelm
Mediamix V Disthelm
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MLS000069722
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, albendazole
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
Noe Socopharm Brand of Albendazole
Noé socopharm brand OF albendazole
Noe-Socopharm Brand of Albendazole
Noé-socopharm brand OF albendazole
NSC 220008
NSC220008
O-methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamic acid
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer brand OF albendazole
Pfizer Brand of Albendazole
Prestwick_675
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Proftril
S1640_Selleck
SAM002589939
Sanicoopa brand OF albendazole
Sanicoopa Brand of Albendazole
SK And F 62979
SK And F62979
SK And F-62979
SK&F 62979
SK&F62979
SK&F-62979
SKF 62979
SKF62979
SKF-62979
Smith Kline & French Brand of Albendazole
SmithKline beecham brand OF albendazole
SmithKline Beecham Brand of Albendazole
SMR000036735
SPBio_002253
Spectrum_001532
SPECTRUM1503903
Spectrum4_000201
Spectrum5_001567
STK387550
STL046130
STOCK2S-67946
TL8003543
UNII-F4216019LN
V Disthelm, mediamix
V Disthelm, Mediamix
Valbazen
Valdecasas brand OF albendazole
Valdecasas Brand of Albendazole
VU0239747-6
Zental
Zentel
ZINC17146904
|
|
3 |
|
Diethylcarbamazine |
Approved, Investigational, Vet_approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
90-89-1 |
3052
|
Synonyms:
12672-34-3
1642-54-2 (citrate (1:1))
1-Diethylcarbamyl-4-methylpiperazine
4-23-00-00225 (Beilstein Handbook Reference)
5348-97-0
5348-97-0 (mono-hydrochloride)
8028-18-0
84L
90-89-1
AB00053457
AC1L1F2E
AI3-19612
AKOS003268016
Aventis brand OF diethylcarbamazine citrate
Bitirazine
BPBio1_000208
BRD-K45542189-048-05-6
BRN 0143029
BSPBio_000188
BSPBio_002179
C07968
Camin
Camin (TN)
Caracide
Carbamazine
Carbilazine
Caricide
CHEMBL684
CID3052
Citrate, diethylcarbamazine
Cypip
D07825
DB00711
Decacide
Diaethylcarbamazinum
Diethyl carbamazine
Diethylcarbamazin
diethylcarbamazine
Diéthylcarbamazine
Diethylcarbamazine (INN)
Diethylcarbamazine [INN:BAN]
Diethylcarbamazine citrate
Diethylcarbamazine citrate (1:1)
Diethylcarbamazine citrate (1:2)
Diethylcarbamazine L-tartrate (1:1)
Diethylcarbamazine maleate
Diethylcarbamazine monohydrochloride
|
Diethylcarbamazine phosphate (1:1)
Diethylcarbamazinum
Diethylcarbamazinum [INN-Latin]
Dietilcarbamazina
Dietilcarbamazina [INN-Spanish]
Ditrazine base
Ditrazine Base
DivK1c_000548
EINECS 202-023-3
Ethodryl
FR-1031
Hetrazan
IDI1_000548
KBio1_000548
KBio2_001418
KBio2_003986
KBio2_006554
KBio3_001399
KBioGR_001081
KBioSS_001418
Loxuran
LS-110688
Luxuran
Maleate, diethylcarbamazine
MolPort-001-788-448
Monohydrochloride, diethylcarbamazine
N,N-Diethyl-4-methyl-1-piperazinecarboxamide
N,N-diethyl-4-methylpiperazine-1-carboxamide
NCGC00178778-01
NCGC00178778-02
NINDS_000548
Notezine
NSC1364
Prestwick0_000284
Prestwick1_000284
Prestwick2_000284
Prestwick3_000284
Spatonin
SPBio_001203
SPBio_002407
Spectrum_000938
Spectrum2_001022
Spectrum3_000390
Spectrum4_000511
Spectrum5_000877
UNII-V867Q8X3ZD
|
|
4 |
|
Doxycycline |
Approved, Investigational, Vet_approved |
Phase 4,Phase 3,Phase 2 |
|
564-25-0 |
54671203
|
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
24390-14-5
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
41411-66-9 (6-epimer, mono-hydrochloride)
564-25-0
5-Hydroxy-a-6-deoxytetracycline
5-Hydroxy-alpha-6-deoxytetracycline
5-hydroxy-α-6-deoxytetracycline
5-Hydroxy-α-6-deoxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6a-Deoxy-5-oxytetracycline
6alpha-deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
6alpha-Deoxy-5-oxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-Deoxyoxytetracycline
6-Deoxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
Alti-Doxycycline
Anhydrous doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
Deoxymykoin
DivK1c_000345
DMSC (*Fosfatex)
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
DOXCYCLINE ANHYDROUS
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
DOXY
Doxy-Caps
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
doxycycline
|
Doxycycline (200mg/day) or Placebo
Doxycycline (anhydrous)
Doxycycline (INN)
Doxycycline (internal use)
Doxycycline (TN)
Doxycycline anhydrous
DOXYCYCLINE CALCIUM
Doxycycline hyclate
Doxycycline monohydrate
DOXYCYCLINE MONOHYDRATE
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxy-Puren
Doxysol
Doxy-Tabs
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
Liviatin
Lopac0_000405
LS-187766
LS-93868
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
Novo-Doxylin
NSC633557
Nu-Doxycycline
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
Spanor
SPBio_000246
SPBio_002784
Spectrum_000807
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
STOCK1N-34341
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Novum
Vibramycine
Vibra-tabs
Vibravenos
Vivox (*Hyclate)
|
|
5 |
|
Azithromycin |
Approved |
Phase 4,Phase 3,Phase 2,Not Applicable |
|
83905-01-5 |
55185
447043
|
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
121470-24-4
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azadose
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin dihydrate
Azithromycin monohydrate
Azithromycin Monohydrate
Azithromycin pfizer brand
Azithromycine
Azithromycinum
Azitrocin
Azitromax
Azitromicina
Azitromin
Azythromycin
Bayer brand OF azithromycin dihydrate
BIDD:GT0792
Bio-0676
BRN 5387583
BSPBio_002285
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP62,993
CP-62993
CPD000471864
DCH3
Dihydrate, azithromycin
DivK1c_000233
DRG-0104
Funk brand OF azithromycin dihydrate
Goxal
Hemomycin
HMS1922G12
|
HMS2094M11
HMS500L15
HSDB 7205
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
Lesvi brand OF azithromycin dihydrate
LS-1834
Mack brand OF azithromycin dihydrate
Misultina
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
MolPort-002-507-426
Monohydrate, azithromycin
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
Pfizer brand OF azithromycin
Pfizer brand OF azithromycin dihydrate
Pharmacia brand OF azithromycin dihydrate
SAM002589961
SMR000471864
SPBio_001544
Spectrum_000307
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Sumamed
Toraseptol
Tromix
Ultreon
UNII-JTE4MNN1MD
Vinzam
Vita brand OF azithromycin dihydrate
XZ-450
Zentavion
ZIT
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
Z-Pak
|
|
6 |
|
Praziquantel |
Approved, Investigational, Vet_approved |
Phase 4,Phase 1,Not Applicable |
|
55268-74-1 |
4891
|
Synonyms:
(.+-)-2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1a)isoquinolin-4-one
(11bS)-2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
135526-78-2
2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro- 4H-pyrazino[2,1-a]-isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a)isoquinolin-4-one
2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7-11b-hexahydro-4H-pyrazino(2,1a)isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7-11b-hexahydro-4H-pyrazinoe(2,1a)isoquinolin-4-one
2-Cyclohexanecarbonyl-1,2,3,6,7,11b-hexahydro-pyrazino[2,1-a]isoquinolin-4-one
2-Cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a) isoquinolin-4-one
46648_FLUKA
46648_RIEDEL
5-24-03-00361 (Beilstein Handbook Reference)
55268-74-1
57452-31-0
8440, EMBAY
AB00052075
AC-11670
AC1L1J6N
AKOS000541869
Azinox
BAS 00347357
Bay-8440
Bayer brand OF praziquantel
Bayer Brand of Praziquantel
Biliricide
Biltricide
Biltricide (TN)
Biltricide, Droncit, Praziquantel
Bio-0456
BPBio1_000088
BRD-A21858158-001-05-2
BRN 0761557
BSPBio_000080
BSPBio_002199
C07367
CCRIS 4114
Cesol
CHEMBL976
CID4891
Cisticid
CPD000037139
Cutter
Cutter Tape Tabs
Cysticide
D00471
D011223
DB01058
DivK1c_000130
Droncit
Drontsit
EINECS 259-559-6
EINECS 260-741-2
Embay 8440
EMBAY 8440
EMBAY-8440
EU-0100909
HMS1568D22
HMS1920J06
HMS2090J19
HMS2092A09
HMS500G12
|
I06-0088
IDI1_000130
InChI=1/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H
KBio1_000130
KBio2_001599
KBio2_004167
KBio2_006735
KBio3_001699
KBioGR_000963
KBioSS_001599
Lopac0_000909
LS-23174
LS-7155
Merck brand OF praziquantel
Merck Brand of Praziquantel
MLS000028528
MLS000038419
MLS001201812
MLS001304085
MolPort-001-926-470
NCGC00015818-05
NCGC00015818-11
NCGC00089733-02
NCGC00089733-03
NCGC00089733-04
NCGC00089733-05
NINDS_000130
NPFAPI-02
Oprea1_163497
P 4668
P4668_SIGMA
Prasiquantel
praziquantel
Praziquantel (JAN/USP/INN)
Praziquantel [USAN:INN:BAN:JAN]
Praziquantel, (+-)-isomer
Praziquantel, (+-)-Isomer
Praziquantel, (R)-isomer
Praziquantel, (R)-Isomer
Praziquantel, (S)-isomer
Praziquantel, (S)-Isomer
Praziquantelum
Praziquantelum [INN-Latin]
Prestwick_402
Prestwick0_000260
Prestwick1_000260
Prestwick2_000260
Prestwick3_000260
Pyquiton
S1691_Selleck
SAM002264632
SMR000037139
SPBio_001295
SPBio_002299
Spectrum_001119
SPECTRUM1500494
Spectrum2_001288
Spectrum3_000550
Spectrum4_000482
Spectrum5_001064
STK030186
Traziquantel
UNII-6490C9U457
|
|
7 |
|
Anti-Infective Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
8 |
|
Antiprotozoal Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
9 |
|
Antiparasitic Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
10 |
|
Antimitotic Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
11 |
|
Anthelmintics |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
12 |
|
Lipoxygenase Inhibitors |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
13 |
|
Anti-Bacterial Agents |
|
Phase 4,Phase 3,Phase 2,Not Applicable |
|
|
|
14 |
|
Antimalarials |
|
Phase 4,Phase 3,Phase 2 |
|
|
|
15 |
|
Anticonvulsants |
|
Phase 4 |
|
|
|
16 |
|
Petrolatum |
Approved, Investigational |
Phase 3 |
|
8009-03-8 |
|
Synonyms:
Multi-hydrocarbon
Paraffinum album
Paraffinum flavum
Petrolatum base
Petrolatum, white
Petrolatum,amber
|
Petrolatum,white
Petroleum jelly
Soft paraffin
White petrolatum
White, soft paraffin
Yellow soft paraffin
|
|
17 |
|
Glycerol |
Approved, Investigational |
Phase 3 |
|
56-81-5 |
753
|
Synonyms:
1,2,3-propanetriol
1,2,3-Propanetriol
1,2,3-trihydroxypropane
1,2,3-Trihydroxypropane
Bulbold
Cristal
e 422
Emery 916
Glyceol opthalgan
Glycerin
Glycerin, anhydrous
Glycerin,anhydrous
Glycerine
glycérine
Glycerinum
Glyceritol
Glycerol
glycérol
|
Glycerolum
Glycyl alcohol
Glyrol
Glysanin
Glyzerin
Gro
IFP
Incorporation factor
Mackstat H 66
Monoctanoin component D
Oelsuess
Ölsüß
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Trihydroxypropane
Tryhydroxypropane
|
|
18 |
|
Disinfectants |
|
Phase 3 |
|
|
|
19 |
|
Protective Agents |
|
Phase 3 |
|
|
|
20 |
|
Eusol |
|
Phase 3 |
|
|
|
21 |
|
Sodium hypochlorite |
|
Phase 3 |
|
|
|
22 |
|
Vitamins |
|
Phase 3 |
|
|
|
23 |
|
Milbemycin |
|
Phase 3,Phase 2 |
|
|
|
24 |
|
Reslizumab |
Approved, Investigational |
Phase 2 |
|
|
|
25 |
|
Rifampicin |
Approved |
Phase 2 |
|
13292-46-1 |
5458213
5381226
|
Synonyms:
13292-46-1
1-b]furan-21-yl acetate
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
Abrifam
Archidyn
Arficin
Arzide
AZT + Rifampin
Ba 41166
Ba 41166/E
BA-41166E
Benemicin
Benemycin
BIDD:PXR0014
Bio-0621
BPBio1_000561
BSPBio_000509
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
DRG-0109
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
nchembio884-comp4
|
NCI60_000309
NINDS_000550
NSC 113926
NSC113926
NSC-113926
Piperine & Rifampicin
Prestwick_833
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
Ramp
RAMP
R-Cin
Reserpine & Rifampicin
Rf
Rfamipicin
RFP
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin Iv
Rifadin IV
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin [INN:BAN:JAN]
Rifampicin SV
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
rifampin
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin Amp
Rifamycin AMP
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
RMP
Rofact
S1764_Selleck
SAM002264646
Sinerdol
SMR000058322
SMR000653525
SPBio_002430
Spectrum_000439
SPECTRUM1500529
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
STK080143
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
|
|
26 |
|
Dihydroartemisinin |
Experimental, Investigational |
Phase 2 |
|
71939-50-9 |
6918483
|
Synonyms:
(3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepin-10-ol
[3R-(3.alpha.,5a.beta.,6.beta.,8a.beta.,9.alpha.,10.alpha.,12.beta.,12aR*)]-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4.3-j]-1,2-benzodioxepin
1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol(Dihydroartemisinin)
71939-50-9
81496-81-3
AC1L32PY
AC1L9UV6
AC-2067
Ambotz71939-50-9
Artenimol
Artenimol (INN)
beta-Dihydroartemisinin
CHEBI:207229
CHEMBL25164
CID107770
|
CID456410
CID6918483
Cotecxin
D07362
D3793
Dihydroartemisinin
Dihydroartemisinine
Dihydroqinghaosu
Dihydroquinghaosu
Dihydroquinghoasu
GNF-PF-5634
JAV-110
LS-64240
VM3352
|
|
27 |
|
Piperaquine |
Experimental, Investigational |
Phase 2 |
|
4085-31-8 |
5079497
|
Synonyms:
1,3-bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
1,3-bis[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propane
4,4'-(propane-1,3-diyldipiperazine-4,1-diyl)bis(7-chloroquinoline)
4085-31-8
5-23-03-00072 (Beilstein Handbook Reference)
7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline
83764-65-2
AC1L3UA1
AC1Q3T7B
AR-1F7471
BRN 0905079
|
C29H32Cl2N6
CHEMBL303933
CID122262
FT-0082661
I06-1673
LS-142194
piperaquine
Piperaquinoline
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro- (9CI)
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-)
ST51053186
|
|
28 |
|
Artemisinine |
|
Phase 2 |
|
|
|
29 |
|
Artemisinins |
|
Phase 2 |
|
|
|
30 |
|
Anti-Asthmatic Agents |
|
Phase 2 |
|
|
|
31 |
|
Antibodies, Monoclonal |
|
Phase 2 |
|
|
|
32 |
|
Antibodies |
|
Phase 2 |
|
|
|
33 |
|
Respiratory System Agents |
|
Phase 2 |
|
|
|
34 |
|
Immunoglobulins |
|
Phase 2 |
|
|
|
35 |
|
Antitubercular Agents |
|
Phase 2 |
|
|
|
36 |
|
Antibiotics, Antitubercular |
|
Phase 2 |
|
|
|
37 |
|
Cytochrome P-450 CYP3A Inducers |
|
Phase 2 |
|
|
|
38 |
|
Nucleic Acid Synthesis Inhibitors |
|
Phase 2 |
|
|
|
39 |
|
Imatinib Mesylate |
|
Phase 2 |
|
220127-57-1 |
123596
|
40 |
|
Protein Kinase Inhibitors |
|
Phase 2 |
|
|
|
41 |
|
Romidepsin |
Approved, Investigational |
Phase 1 |
|
128517-07-7 |
5352062
|
Synonyms:
(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
128517-07-7
AC1NS1N3
Antibiotic FR 901228
C087123
C24H36N4O6S2
CHEBI:61080
CHEMBL343448
Chromadax
Chromadax (TN)
chromodax
CID5352062
Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (3?5)-disulfide"
D06637
FK 228
FK228
|
FK-228
FK-901228
FR 901228
FR901228
FR-901228
HDInhib_000006
Istodax
LS-161318
L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide
nchembio.313-comp2
NSC 630176
NSC630176
NSC-630176
Probes1_000153
Probes2_000337
Romidepsin
Romidepsin (USAN)
romidepsina
|
|
42 |
|
Pharmaceutical Solutions |
|
Phase 1 |
|
|
|
43 |
|
Mebendazole |
Approved, Vet_approved |
|
|
31431-39-7 |
4030
|
Synonyms:
(5-Benzoyl-1H-benzimidazol-2-yl)-carbamate methyl ester
(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
(5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
(5-Benzoyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI)
31431-39-7
46404_FLUKA
46404_RIEDEL
5-Benzoyl-2-benzimidazolecarbamic acid methyl ester
5-Benzoyl-2-benzimidazolecarbamic acid, methyl ester
AB00052203
abello Farmacia brand OF mebendazole
Abello Farmacia Brand of Mebendazole
AC-12064
AC1L1H98
AC1Q44DR
AKOS000539066
Anti worm
Anti Worm
Anti-worm
Anti-Worm
Ardeypharm brand OF mebendazole
Ardeypharm Brand of Mebendazole
Bantenol
Banworm
BAS 00341140
Besantin
BIDD:GT0087
Bio-0458
Bio-0803
Boots brand OF mebendazole
Boots Brand of Mebendazole
Boots threadworm treatment
Boots Threadworm Treatment
BPBio1_000257
BRD-K77987382-001-01-7
BRD-K77987382-001-06-6
BSPBio_000233
BSPBio_003178
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester (9CI)
Carbamic acid, N-(5-benzoylbenzimidazol-2-yl)-, methyl ester
CAS-31431-39-7
CBDivE_010559
CCRIS 4479
CHEBI:6704
CHEMBL685
CID4030
CPD000036734
D00368
D008463
DB00643
Degort's brand OF mebendazole
Degort's Brand of Mebendazole
Diba brand OF mebendazole
Diba Brand of Mebendazole
DivK1c_000751
EINECS 250-635-4
Elfar brand OF mebendazole
Elfar Brand of Mebendazole
Equivurm Plus
Esteve brand OF mebendazole
Esteve Brand of Mebendazole
Healthypharm brand OF mebendazole
Healthypharm Brand of Mebendazole
HMS1536H11
HMS1568L15
HMS1921F03
HMS2090B03
HMS2092B15
HMS502F13
HSDB 3232
I06-2075
IDI1_000751
Janssen brand OF mebendazole
Janssen Brand of Mebendazole
KBio1_000751
KBio2_001778
KBio2_004346
KBio2_006914
KBio3_002398
KBioGR_000712
KBioSS_001778
Leidapharm brand OF mebendazole
Leidapharm Brand of Mebendazole
Lomper
LS-48951
M2523_FLUKA
M2523_SIGMA
Madicure
MBDZ
Mebendan
Mebendazol
Mebendazol [INN-Spanish]
mebendazole
|
Mébendazole
Mebendazole (JAN/USP)
Mebendazole (JAN/USP/INN)
Mebendazole [USAN:INN:BAN:JAN]
Mebendazole(USAN)
MEBENDAZOLE, 99%
Mebendazolum
Mebendazolum [INN-Latin]
Mebenoazole
Mebenvet
Mebex
Mebutar
methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl [5-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate
Methyl 5-benzoyl benzimidazole-2-carbamate
Methyl 5-benzoyl-2-benzimidazolecarbamate
Methyl 5-benzoyl-2-benzimidazolylcarbamate
Methyl N-(5-benzoyl-1H-benzimidazol-2-yl)carbamate
Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate
methyl N-(6-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
MLS000028491
MolPort-000-765-625
MolPort-001-889-615
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle [French]
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle [French]
NCGC00016806-01
NCGC00016806-02
NCGC00021698-03
NCGC00021698-04
NCGC00021698-05
NCGC00021698-06
NINDS_000751
Norgine brand OF mebendazole
Norgine Brand of Mebendazole
Noverme
NSC 184849
NSC184849
Oprea1_278237
Oprea1_768530
Ovitelmin
Pantelmin
Pfizer brand OF mebendazole
Pfizer Brand of Mebendazole
Prestwick_310
Prestwick0_000217
Prestwick1_000217
Prestwick2_000217
Prestwick3_000217
Pripsen mebendazole
Pripsen Mebendazole
Probes1_000013
Probes2_000149
R 17,635
R 17635
R17635
R-17635
SAM002548959
SMR000036734
SPBio_001442
SPBio_002154
Spectrum_001298
SPECTRUM1501110
Spectrum2_001401
Spectrum3_001439
Spectrum4_000416
Spectrum5_001381
Sqworm
SSL Brand of Mebendazole
SSL Brand OF mebendazole
STK093862
Streger brand OF mebendazole
Streger Brand of Mebendazole
Sufil
Surfont
Taxandria brand OF mebendazole
Taxandria Brand of Mebendazole
Tedec meiji brand OF mebendazole
Tedec Meiji Brand of Mebendazole
Telmin
TimTec1_000869
TL8002405
UNII-81G6I5V05I
Vermicidin
Vermicol
Vermidil
Vermin
Vermirax
Vermox
Vermox (TN)
Verpanyl
Versid
Wormkuur
ZINC00121541
|
|
44 |
|
Piperazine |
Approved, Vet_approved |
|
|
110-85-0 |
4837
|
Synonyms:
1,4-Diazacyclohexane
1,4-Diethylenediamine
1,4-Piperazine
110-85-0
14007-05-7 (unspecified hydrobromide)
142-63-2 (hexahydrate)
142-64-3 (di-hydrochloride)
14538-56-8 (phosphate[1:1])
16832-43-2 (unspecified hydrate)
1951-97-9 (unspecified phosphate)
3597-26-0 (unspecified sulfate)
5-23-01-00030 (Beilstein Handbook Reference)
6094-40-2 (unspecified hydrochloride)
7542-23-6 (mono-hydrochloride)
8017-90-1
8027-81-4
8057-14-5 (unspecified salt)
80621_FLUKA
854880-15-2
861800-35-3
AB1003720
AC1L1J2E
AC1Q1IA7
AC1Q1IA8
AC1Q1IA9
AKOS000269028
Anthalazine
Antiren
AR-1L1009
ARONIS23910
Asca-Trol No. 3
BIDD:GT0273
BRN 0102555
C07973
CCRIS 5950
CHEBI:28568
CHEMBL1412
CID4837
D00807
DB00592
Diethylenediamine
Diethyleneimine
Dispermine
DivK1c_000038
EINECS 203-808-3
Eraverm
Eraverm (VAN)
Fluphenazine dihydrochloride
Hexahydro-1,4-diazine
Hexahydropyrazine
HMS1920H20
HMS2092A03
HMS500B20
HSDB 1093
I14-11172
IDI1_000038
InChI=1/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H
Jsp000824
KBio1_000038
KBio2_001593
KBio2_004161
KBio2_006729
KBioSS_001593
LS-517
LTBB000432
Lumbrical
MolPort-000-872-010
NCGC00094762-01
NCGC00094762-02
nchembio814-comp12
NCIOpen2_000984
NCIOpen2_000988
NCIOpen2_001024
NCIOpen2_001031
NCIOpen2_001033
NCIOpen2_001071
NCIOpen2_001073
NCIOpen2_001111
NCIOpen2_001151
NCIOpen2_001231
NCIOpen2_001262
NCIOpen2_001269
|
NCIOpen2_004830
NCIOpen2_004834
NCIOpen2_004862
NCIOpen2_004874
NCIOpen2_004904
NCIOpen2_004910
NCIOpen2_004914
NCIOpen2_004942
NCIOpen2_004952
NCIOpen2_004954
NCIOpen2_004982
NCIOpen2_004992
NCIOpen2_004994
NCIOpen2_005022
NCIOpen2_005032
NCIOpen2_005034
NCIOpen2_005062
NCIOpen2_005072
NCIOpen2_005102
NCIOpen2_005108
NCIOpen2_005145
NCIOpen2_005182
NCIOpen2_005185
NCIOpen2_005187
NCIOpen2_005200
NCIOpen2_005575
NCIOpen2_005980
NCIOpen2_009422
NINDS_000038
NSC 474
NSC474
P0446
P0447
P45907_SIAL
Piperazidine
Piperazin
Piperazin [German]
Piperazin [Germany]
piperazine
PIPERAZINE (HEXAHYDRATE)
Piperazine (USP)
Piperazine [UN2579] [Corrosive]
Piperazine [UN2579] [Corrosive]
Piperazine [USAN]
Piperazine anhydrous
Piperazine diacetate
Piperazine dihydrochloride
Piperazine Dihydrochloride Dihydrochloride Hydrate
Piperazine hexahydrate
Piperazine Hexa-Hydrate
Piperazine hydrate
Piperazine hydrobromide
Piperazine hydrochloride
Piperazine monohydrochloride
Piperazine phosphate
Piperazine phosphate (1:1)
Piperazine salt
Piperazine sulfate
Piperazine tartrate (1:1), (R-(r*,r*))-isomer
Piperazine tartrate, (R-(r*,r*))-isomer
Piperazine, anhydrous
piperazinium oleate
Piperazinium oleate
Pipersol
Pripsen
Pyrazine hexahydride
Pyrazine, hexahy
PZE
Spectrum_001113
SPECTRUM1500490
Spectrum5_001817
UN2579
UNII-1RTM4PAL0V
Upixon
Uvilon
Vermex
Vermizine
Vermizine (TN)
WLN: T6M DMTJ
Worm-A-Ton
Worm-away
Wurmirazin
|
|
45 |
|
Permethrin |
Approved, Investigational |
Not Applicable |
|
52645-53-1 |
40326
|
Synonyms:
(+-)-cis-Fmc 33297
(+-)-cis-Permethrin
(+)-CIS-PERMETHRIN
(+)-trans-Permethrin
(+-)-trans-Permethrin
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid
(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate
(m-Phenoxybenzyl)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
[3-(phenyloxy)phenyl]methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
1RS,cis-Permethrin
1RS-trans-Permethrin
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylate, (3-phenoxyphenyl) methyl ester
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester
3-phenoxybenzyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
3-Phenoxybenzyl-(+-)-cis,trans-2,2-dichlorovinyl-2,2-dimethyl-cyclopropylcarboxylic acid, ester
3-Phenoxybenzyl-cis,trans-(1Rs)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
3-Phenoxybenzyle (1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylate
442748_SUPELCO
45614_FLUKA
45614_RIEDEL
45893_FLUKA
45893_RIEDEL
47956_SUPELCO
52341-32-9
52341-33-0
52645-53-1
AC1L23IC
AC1Q3FFG
Acticin Cream
AI3-29296
Ambush
BRN 4153590
C21H20Cl2O3
CHEBI:34911
CHEMBL1525
CID40326
cis Permethrin
cis-(1Rs)-Permethrin
cis-Permethrin
DB04930
Elimite
Elimite Cream
FMC 35171
LS-58636
LS-58640
|
MLS001332525
MLS001332526
MolPort-003-933-021
NCGC00159390-00
NCGC00159390-02
NCGC00159390-04
NCGC00159390-05
NCGC00159390-06
NCGC00159390-07
NCGC00159390-08
NCGC00159390-09
Nittifor
Nix Cream Rinse
NRDC 143
NRDC 146
NRDC 147
NRDC 148
NRDC143
NRDC-143
NRDC147
NRDC-147
PerFoam
Permethrin
Permethrin (isomers)
Permethrin (isomers) solution
Permethrin, (1R-cis)-isomer
Permethrin, (1R-trans)-isomer
Permethrin, (1S-cis)-isomer
Permethrin, (1S-trans)-isomer
Permethrin, (cis-(+-))-isomer
Permethrin, (cis)-isomer
Permethrin, (trans-(+-))-isomer
Permethrin, (trans)-isomer
Permethrin, cis-(1Rs)-isomer
Permethrin, trans-(1Rs)-isomer
Permethrine,c&t
PS758_SUPELCO
SMR000778043
ST50975270
TL8003462
trans Permethrin
trans-(+-)-Permethrin
trans-(1Rs)-Permethrin
trans-Permethrin
Transpermethrin
Transpermethrin [ISO]
|
|
46 |
|
Citric Acid |
Approved, Nutraceutical, Vet_approved |
|
|
77-92-9 |
311
|
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-carboxy-3-hydroxypentane-1,5-dioic acid
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
|
Citretten
Citric acid monoglyceride
Citric acid monohydrate
Citric acid, anhydrous
Citric Acid, Anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
H3Cit
Hydrocerol a
Kyselina citronova
Monohydrate, citric acid
Suby g
Uralyt u
uro-Trainer
|
|
47 |
|
Suramin |
Investigational |
|
|
145-63-1 |
5361
|
Synonyms:
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis- (9CI)
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-, hexasodium salt
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di- (8CI)
1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt
129-46-4 (hexa-hydrochloride salt)
145-63-1
3-14-00-02267 (Beilstein Handbook Reference)
8,8'-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bisnaphthalene-1,3,5-trisulphonic acid
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonate
8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC
8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonIC ACID
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulphonate
8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulphonic acid
8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-napthalenetrisulfonic acid
8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bisnaphthalene-1,3,5-trisulphonic acid
8,8'-[Ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-1,3,5-naphthalenetrisulfonic acid
8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid
AC1L1K6K
Antrypol
Bayer 205
Belganyl
BRN 3230873
BSPBio_002248
C07974
C51H40N6O23S6
CHEBI:45906
CHEMBL265502
CID5361
DB04786
DivK1c_006758
EINECS 205-658-4
Farma
Farma 939
Fourneau
Germanin
Harnstoff, symmetischer der 3-aminobenzoyl-3-amino-4-methylbenzoyl-1-naphthylamin-4,6,8-trisulfonsaeure
Hexasodium salt suramin
KBio1_001702
KBio2_002397
|
KBio2_004965
KBio2_007533
KBio3_001468
KBioGR_001774
KBioSS_002402
L000585
Lopac0_001182
LS-95867
m,m'-Ureylen-bis-(8-(m-(benzamido)-p-toluamido)naphthalin-1,3,5-trisulfonsaeure)
Monosodium salt suramin
Moranil
Moranyl
Naganil
Naganin
Naganine
Naganol
Naganol 6 Na
Naphuride
NCGC00163318-01
NSC 34936
NSC34936
Salt suramin, hexasodium
Salt suramin, monosodium
SGCTO-001
Sodium suramin
Sodium, suramin
SpecPlus_000662
Spectrum_001877
Spectrum3_000724
Spectrum4_001247
suramin
Suramin
Suramin sodium
SURAMIN SODIUM
Suramin, hexasodium salt
Suramin, monosodium salt
Suramine
Suramine sodium
SVR
sym-bis(m-aminobenzoyl-m-amino-p-methylbenzoyl-1-napthylamino-4,6,8-trisulfonate) carbamide
WLN: L66J BSWQ DSWQ GSWQ JMVR D1 CMVR CMVMR CVMR B1 EVM-JL66J BSWQ DSWQ GSWQ &-NA-6
|
|
48 |
|
Citrate |
|
|
|
|
|
49 |
|
Piperazine citrate |
|
|
|
|
|
50 |
|
Liver Extracts |
|
Not Applicable |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 67)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali |
Completed |
NCT02784743
|
Phase 4 |
''albendazole'' and ''ivermectin'' |
2 |
Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis |
Completed |
NCT01593722
|
Phase 4 |
Diethylcarbamazine;Ivermectin |
3 |
Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti Infection |
Completed |
NCT02005653
|
Phase 4 |
Diethylcarbamazine;Albendazole;Doxycycline |
4 |
Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy |
Completed |
NCT03052998
|
Phase 4 |
Ivermectin |
5 |
Twice Yearly Treatment for the Control of LF |
Recruiting |
NCT03036059
|
Phase 4 |
400 μg/kg Ivermectin + 400 mg Albendazole |
6 |
Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH) |
Recruiting |
NCT03014167
|
Phase 4 |
Albendazole |
7 |
Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin |
Not yet recruiting |
NCT03570814
|
Phase 4 |
Administration of Albendazole on Day 1;Administration of Ivermectin on Day 1;Administration of Azithromycin on Day 1;Administration of Azithromycin on Day 15 |
8 |
Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis |
Withdrawn |
NCT01903057
|
Phase 4 |
azithromycin;ivermectin;albendazole;placebo |
9 |
Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis |
Withdrawn |
NCT02734186
|
Phase 4 |
Praziquantel |
10 |
Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study |
Completed |
NCT02509481
|
Phase 2, Phase 3 |
Ivermectin;Albendazole |
11 |
An RCT to Evaluate the Effect of a New Skin Care Regimen on SBF in Those With Podoconiosis |
Completed |
NCT02839772
|
Phase 3 |
|
12 |
IVM Alone vs ALB + IVM Against Onchocerciasis |
Completed |
NCT03238131
|
Phase 3 |
Ivermectin;Albendazole |
13 |
Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection |
Completed |
NCT00790998
|
Phase 3 |
Moxidectin;Ivermectin |
14 |
A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali |
Recruiting |
NCT02927496
|
Phase 3 |
Doxycycline;Placebo |
15 |
A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka |
Recruiting |
NCT02929134
|
Phase 3 |
Doxycycline;Placebo |
16 |
Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana |
Active, not recruiting |
NCT02078024
|
Phase 3 |
IVM plus ALB;IVM |
17 |
A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India |
Not yet recruiting |
NCT02929121
|
Phase 3 |
Doxycycline;Placebo |
18 |
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) |
Not yet recruiting |
NCT03676140
|
Phase 3 |
Albendazole on Day 1;Ivermectin on Day 1;Diethylcarbamazine on day 1;Azithromycin on Day 1;Azithromycin on Day 8 |
19 |
Effect of Albendazole Dose on Treatment of Lymphatic Filariasis |
Completed |
NCT00511004
|
Phase 2 |
Albendazole;Diethylcarbamazine |
20 |
Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis |
Completed |
NCT00340691
|
Phase 2 |
Doxycycline |
21 |
Effect of Albendazole Dose on Clearance of Filarial Worms |
Completed |
NCT00339417
|
Phase 2 |
Albendazole;Ivermectin |
22 |
Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa |
Completed |
NCT01975441
|
Phase 2 |
Diethylcarbamazine;Albendazole;Ivermectin |
23 |
Effect of Albendazole Dose on Clearance of Filarial Worms |
Completed |
NCT00375583
|
Phase 2 |
DEC/Albendazole |
24 |
Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study |
Completed |
NCT02511353
|
Phase 2 |
ivermectin;placebo;dihydroartemisinin-piperaquine |
25 |
Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis |
Completed |
NCT01111305
|
Phase 2 |
Reslizumab;Diethylcarbamazine |
26 |
Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection |
Completed |
NCT00300768
|
Phase 2 |
2 mg moxidectin;ivermectin 150 mcg/kg;4 mg moxidectin;8 mg moxidectin |
27 |
Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness |
Completed |
NCT00127504
|
Phase 2 |
Rifampin;Azithromycin |
28 |
Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana |
Completed |
NCT02281643
|
Phase 2 |
Doxycycline |
29 |
PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs ) |
Not yet recruiting |
NCT03664063
|
Phase 2 |
Azithromycin;Albendazole;Ivermectin;Diethylcarbamazine |
30 |
Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa |
Not yet recruiting |
NCT02644525
|
Phase 2 |
Imatinib Mesylate;Placebo |
31 |
Pediatric Pharmacokinetics And Safety Study Of Moxidectin |
Withdrawn |
NCT01035619
|
Phase 2 |
moxidectin |
32 |
Relative Bioavailability Study of Emodepside IR-tablets and Solution |
Completed |
NCT03383523
|
Phase 1 |
Emodepside (BAY 44-4400) |
33 |
First in Man Clinical Trial of Emodepside (BAY 44-4400) |
Completed |
NCT02661178
|
Phase 1 |
emodepside (BAY 44-4400);placebo |
34 |
Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside |
Recruiting |
NCT03383614
|
Phase 1 |
LSF emodepside (BAY 44-4400) oral solution (1mg/mL) |
35 |
Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE) |
Active, not recruiting |
NCT02845713
|
Phase 1 |
Ivermectin, Diethylcarbamazine Albendazole (IDA) |
36 |
Exhaled NO Testing in Filariasis |
Completed |
NCT01628497
|
|
|
37 |
Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India |
Completed |
NCT01629771
|
|
|
38 |
Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis |
Completed |
NCT01905423
|
|
Albendazole and diethylcarbamazine |
39 |
Research for Elim of Filariasis |
Completed |
NCT00145223
|
|
|
40 |
Research for Elimination of Lymphatic Filariasis (ICIDR) |
Completed |
NCT00406627
|
|
|
41 |
Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast) |
Completed |
NCT02032043
|
|
Annual versus Semiannual Albendazole plus Ivermectin MDA |
42 |
Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia |
Completed |
NCT01905436
|
|
Annual versus Semiannual Albendazole plus Ivermectin Mass Drug Administration |
43 |
Interaction Between HIV and Lymphatic Filariasis |
Completed |
NCT00295698
|
Not Applicable |
Diethylcarbamazine |
44 |
Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji |
Completed |
NCT03177993
|
Not Applicable |
3 drug dose - IDA;3 drug dose - IDA with second dose of ivermectin;2 drug dose - DA |
45 |
Medical Implications of Coinfection With Malaria and Filariasis Parasites |
Completed |
NCT00471666
|
|
|
46 |
Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination |
Completed |
NCT01586169
|
Not Applicable |
triple co administration at once of the combination of Albendazole + ivermectin + azithromycin |
47 |
Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area |
Completed |
NCT00139100
|
Not Applicable |
antimicrobial agent in soap |
48 |
Prevalence of LF Infection in Districts Not Included in LF Control Activities |
Completed |
NCT03131401
|
|
|
49 |
Changes in HIV Viral Load in Patients Undergoing Treatment for Filariasis |
Completed |
NCT00344279
|
|
|
50 |
Promoting Consistent Shoe Use Among Children At High Risk for Podoconiosis |
Completed |
NCT01160523
|
|
|
Inferred drug relations via
UMLS
73
/
NDF-RT
51
:
|